Faculty

Steve Schwartz

Professor, Epidemiology

206-685-1799

Education

PhD Epidemiology, University of Washington, 1990
MPH Epidemiology, Yale University, 1984

Contact

206-685-1799

University of Washington
Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 861B
Seattle, WA 98195

Research Areas

Research Interests

Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.

Recent Publications (PubMed)

Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study.
(2025 Mar 6)
Am J Hum Genet 112(3): 630-643
Ugalde-Morales E, Wilf R, Pluta J, Ploner A, Fan M, Damra M, Aben KK, Anson-Cartwright L, Chen C, Cortessis VK, Daneshmand S, Ferlin A, Gamulin M, Gietema JA, Gonzalez-Niera A, Grotmol T, Hamilton RJ, Harland M, Haugen TB, Hauser R, Hildebrandt MAT, Karlsson R, Kiemeney LA, Kim J, Lessel D, Lothe RA, Loveday C, Chanock SJ, McGlynn KA, Meijer C, Nead KT, Nsengimana J, Popovic M, Rafnar T, Richiardi L, Rocca MS, Schwartz SM, Skotheim RI, Stefansson K, Stewart DR, Turnbull C, Vaughn DJ, Winge SB, Zheng T, Monteiro AN, Almstrup K, Kanetsky PA, Nathanson KL, Wiklund F, Testicular Cancer Consortium
Enhancing survivorship care among Hispanic/Latino cancer survivors via lay health educators: results of a pilot randomized trial.
(2025 Feb 15)
J Cancer Surviv
Chow EJ, Blythe NA, Cushing-Haugen KL, Duggan C, Baker KS, Cole AM, Green S, Guiterrez AI, Lee E, Linden HM, Mendoza JA, Ohlsen TJD, Ortblad KF, Schwartz SM, Yung RL, Ceballos RM
Historical redlining and survival among children, adolescents, and young adults with cancer diagnosed between 2000-2019 in Seattle and Tacoma, Washington.
(2025 Feb 1)
Cancer 131(3): e35677
Karvonen KA, Doody DR, Barry D, Bona K, Winestone LE, Rosenberg AR, Mendoza JA, Schwartz SM, Chow EJ
Data-Driven Community Engagement: Using Quantitative and Qualitative Data to Set Priorities and Launch New Initiatives in a Growing Catchment Area.
(2024)
Prev Oncol Epidemiol 2(1):
McDougall JA, Briant KJ, Carosso E, Cole AM, Dee C, Doody DR, Hannon PA, Henderson V, Johnson S, Parker M, Schwartz SM, Mendoza JA
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.
(2024 Dec 15)
Cancer 130(24): 4298-4305
Mukand NH, Chirikova E, Lichtensztajn D, Negoita S, Aboushwareb T, Bennett J, Brooks JD, Leppert JT, Chung BI, Li C, Schwartz SM, Gershman ST, Insaf T, Morawski BM, Stroup A, Wu XC, Doherty JA, Petkov VI, Zambon JP, Gomez SL, Cheng I
Show complete publication list